Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2023-04-11 00:00:00 ET · period of report 2023-04-10 · accession 0001415889-23-006441 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-11 | 2023-04-10 | KNSA | Ragosa Mark | CFO | M - OptEx | — | +2,695 | 12.5K | +27% | — |
| D | 2023-04-11 | 2023-04-10 | KNSA | Ragosa Mark | CFO | F - Tax | $10.71 | -791 | 11.7K | -6% | -$8,472 |
| D | 2023-04-11 | 2023-04-10 | KNSA | Ragosa Mark | CFO | M - OptEx | $0.00 | +2,695 | 8,082 | +50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Share | 2023-04-10 | M | A | 2,695 | — | 12,506 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. |
| 2 | Common | Class A Common Share | 2023-04-10 | F | D | 791 | $10.71 | 11,715 | D | — | — | |
| 3 | Derivative | Restricted Share Unit | 2023-04-10 | M | A | 2,695 | $0.00 | 8,082 | D | — · — to — | 2,695 Class A Common Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F2) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 7, 2022. |